BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260406
DTEND;VALUE=DATE:20260409
DTSTAMP:20260514T232915
CREATED:20251119T144046Z
LAST-MODIFIED:20251119T144046Z
UID:42432-1775433600-1775692799@www.pharmajournalist.com
SUMMARY:5th LNP Formulation & Process Development Summit
DESCRIPTION:Returning to Boston in April 2026\, the 5th LNP Formulation & Process Development Summit is the only industry-led meeting covering end-to-end LNP development. This Summit will be providing the latest scientific content to advance your LNP development for a variety of payloads and therapeutic applications\, from mRNA vaccines to next-generation cell and gene therapies. \nThe 2026 program will dive into 3 parallel tracks\, including: Analytical Development & Characterization\, Formulation & Delivery and Process Development & Manufacturing. This is your opportunity to divide and conquer\, where you can send different members across your team amongst 250+ LNP innovators\, to ensure you gain a comprehensive understanding of the entire LNP development pipeline. From early formulation through to commercial-scale production\, you can return to your company equipped with the insights needed to accelerate your LNP-mediated medicines. \nLearn more in the official event guide here: https://ter.li/y6ipkw \nCurated in collaboration with our Scientific Advisory Board\, Annette Bak (AstraZeneca)\, Luis Brito (Beam Therapeutics)\, and Ching Kim Tye (Sanofi)\, this premier forum is designed to deliver LNP-specific networking and knowledge sharing. Our unmissable agenda highlights include: \n\nAttracting Investment & Acquisition Opportunities with Capstan Therapeutics\, GV and Chiesi Global Rare Diseases\nAchieving Extrahepatic Targeting with LNPs with Alnylam\, Servier and Novartis\nLNPs for Cell & Gene Therapy Delivery with Yoltech Therapeutics\, Innorna and Corner Therapeutics\nInteractive LNP-Focused Workshop Day with Novo Nordisk\, GSK and Editas Medicines\nGain a Refresher on LNP Core Principles with Land Therapeutics\, Beam Therapeutics and Arbor Biotechnology\nFormulating Thermostable LNPs with Eli Lilly & Co and AstraZeneca\n\nKeen to find out more? Access our event overview on the LNP website here: https://ter.li/y6ipkw
URL:http://www.pharmajournalist.com/event/5th-lnp-formulation-process-development-summit/
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR